
CMTA Invests $423,000 in Solve-CMT Initiative to Advance Gene Discovery
GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $423,000 investment in the Solve-CMT initiative, a groundbreaking effort aimed at addressing diagnostic challenges and spurring new gene discoveries for Charcot-Marie-Tooth …
CMTA Invests $423,000 in Solve-CMT Initiative to Advance Gene Discovery Read More